A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cells.

Autor: Martelli, A.M.1,2, Tazzari, P.L.3, Tabellini, G.1, Bortul, R.4, Billi, A.M.1, Manzoli, L.1, Ruggeri, A.1, Conte, R.3, Cocco, L.1
Zdroj: Leukemia (08876924). Sep2003, Vol. 17 Issue 9, p1794-1805. 12p.
Databáze: Academic Search Ultimate